Drug interactions
Emtricitabine + Lovotibeglogene autotemcel
Severity: Major
Emtricitabine and Lovotibeglogene autotemcel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Antiretroviral exposure during cell collection may impair lentiviral transduction and reduce the quality of the manufactured gene therapy, which may affect treatment success.
What this interaction means in plain words
Emtricitabine and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Reverse transcriptase inhibitors can interfere with lentiviral vector transduction during manufacturing.
What to do
Discontinue emtricitabine at least 1 month before mobilization and until all apheresis cycles are complete. Coordinate the interruption with an HIV specialist.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Emtricitabine and Lovotibeglogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Emtricitabine
Frequently asked questions
Can I take Emtricitabine with Lovotibeglogene autotemcel?
MediHelp rates the interaction as major. Emtricitabine and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Antiretroviral exposure during cell collection may impair lentiviral transduction and reduce the quality of the manufactured gene therapy, which may affect treatment success.
How serious is the interaction between Emtricitabine and Lovotibeglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue emtricitabine at least 1 month before mobilization and until all apheresis cycles are complete. Coordinate the interruption with an HIV specialist.
What other medicines interact with Emtricitabine?
MediHelp also lists interactions of Emtricitabine with, for example, Elvitegravir / cobicistat / emtricitabine / tenofovir df, Atidarsagene autotemcel, Betibeglogene autotemcel. The full list is on the Emtricitabine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
